title: CA 15.3 as a signal of undetectable breast cancer metastases in a follow-up period of 4 years.
authors.forename: M
authors.initials: M
authors.lastname: Pizzichetta
authors.forename: A
authors.initials: A
authors.lastname: Bogni
authors.forename: E
authors.initials: E
authors.lastname: Seregni
authors.forename: L
authors.initials: L
authors.lastname: Maffioli
authors.forename: E
authors.initials: E
authors.lastname: de Jager
authors.forename: A
authors.initials: A
authors.lastname: Costa
authors.forename: E
authors.initials: E
authors.lastname: Bombardieri
mesh_terms: D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood / Q000276:immunology; D001943:Breast Neoplasms / Q000097:blood / Q000276:immunology* / Q000556:secondary; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000276:immunology; D009378:Neoplasms, Multiple Primary / Q000097:blood / Q000276:immunology; D013997:Time Factors
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor